v3.19.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net income (loss) $ 471 $ (3,027)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 3,641 2,766
Impairment of property and equipment   632
Stock-based compensation 2,375 1,823
Changes in operating assets and liabilities:    
Accounts receivable 8,482 (3,472)
Prepaid expenses and other assets (303) (891)
Accounts payable (617) 715
Accrued expenses and other current liabilities (73) 860
Deferred revenue (2,825) 3,109
Net cash provided by operating activities 11,151 2,515
Cash flows from investing activities:    
Purchase of property and equipment (3,672) (7,426)
Investment in intangible and other assets (59) (36)
Net cash used in investing activities (3,731) (7,462)
Cash flows from financing activities:    
Proceeds from issuance of common stock upon secondary offering 11,247  
Payment of line of credit costs   (10)
Payments of offering costs (445)  
Proceeds from exercise of stock options 443 523
Repurchases of common stock (3,466)  
Proceeds from exercise of warrants 71 988
Proceeds from employee stock purchase plan 642 421
Net cash provided by financing activities 8,492 1,922
Increase (decrease) in cash, cash equivalents and restricted cash 15,912 (3,025)
Effect of exchange rate on cash and cash equivalents (52) (164)
Cash, cash equivalents and restricted cash at beginning of year 10,278 19,597
Cash, cash equivalents and restricted cash at end of period 26,138 16,408
Supplemental cash flow disclosures:    
Deferred offering costs included in other assets   249
Supplemental disclosure of non-cash operating activities:    
Purchases of property and equipment included in accounts payable $ 26  
Line of Credit    
Supplemental cash flow disclosures:    
Deferred offering costs included in other assets   $ 91

Source